Meta Analysis on Intravenous Antioxidants Therapy in the Treatment of Moderately Severe and Severe Acute Pancreatitis

Sun Wenwu,Wang Jinlong,Sun qinlong,Mao Enqiang
DOI: https://doi.org/10.3760/cma.j.issn.1674-1935.2017.01.007
2017-01-01
Abstract:Objective To investigate the efficacy of intravenous antioxidants therapy in treating moderately severe acute pancreatitis (MSAP) and severe acute pancreatitis (SAP).Methods Pubmed,Embase,Cochrane library and CNKI databases for all randomized control trials published before March 18st,2016 manually was searched by computer.Data on AP associated mortality and length of stay (LOS) were collected.The quality of the trials included was assessed by the Cochrane systematic review method.Results Fifteen trials with data of 620 patients were eligible for final inclusion.Among the 15 trials,detailed randomization for grouping was clearly described in 5 studies and obvious bias was observed in 1 study.Three studies had obvious biases considering whether outcome assessment was blinded,outcome data was incomplete and outcome report was selective.No other apparent bias was found.Statistical analysis showed that compared with control group,intravenous antioxidants administration did not significantly reduce mortality (12.1 vs 9.7,RD=-0.02,95% CI-0.08~-0.03,P=0.44;RR=0.83.95% CI0.51~ 1.34,P=0.44),but could shorten LOS (MD=-2.02;95% CI-4.00~-0.05;P=0.04).Conclusions Intravenous antioxidants could greatly shorten LOS of patients with MSAP and SAP.
What problem does this paper attempt to address?